1European Best Practice Guideline for Section Ⅱ . Hemodialysis adequacy.Nephrol Dial Transplant, 2002,17(Suppl 7): 16
2European Best Practice Guideline for Section Ⅲ . Biocompatibility.Nephrol Dial Transplant, 2002; 17, [ Suppl 7 ]: 32
3Koening W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circluation, 1999,99:237
4Schouten WE, Grooteman MP, van Houte AJ, et al. Effects of dialyser and dialystae on the acute phase reaction in clinical bicarbonate dialysis.Nephrol Dial Transplant, 2000,15:379
5Linnenweber S, Lonnemann G. Effects of dialyzer membrane on interleukin-1β(IL-1β) and IL-1β-convering enzyme in menouclear cells. Kidney Int, 2001,59:282
6Kosch M, Levers A, Fobker M, et al. Dialysis filter typer determines the acute effects of hemodialysis endothelial function and oxidative stress.Nephrol Dial Transplant, 2003,18: 1370
7Cianciolo G, Stefoni S, Donati G, et al. Intra- and post-dialytic platelet activation and PDGF-AB release: cellulose diacetate vs polysulfone membranes. Nephrol Dial Transplant, 2001,16:1222
8Widjaja A, Kielstien JT, Horu R, et al. Free serum leptin but not bound leptin concentrations are elevated in patients with end-stage renal disease.Nephrol Dial Transplant, 2000, 15: 846
9Stein G, Franke S, Mahiout A, et al. Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients. Nephrol Dial Transplant, 2001,16:999
10Van Tellingen A, Grooteman MP, Bartels PC, et al. Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients. Kidney Int, 2001,59:342
